19th EU-China Business Meeting Concludes! Third-Generation Triple-Helix Biomimetic Collagen Medical Devices Make Their Global Debut, Highlights from the Event
CHENGDU, China, Oct. 24, 2026 /PRNewswire/ -- At the 19th EU-China Business Meeting, co-hosted by the China Chamber of International Commerce (CCOIC) and the European Union Chamber of Commerce in China (EUCCC) in Chengdu, LivingPHOENIX Regenerative...
OUE REIT Strengthens Presence in Sydney's CBD with Proposed Acquisition of Additional c.50% Interest in 180 George Street for an Agreed Property Price of A$864.0 million
Raises OUE REIT's interest in 180 George Street from 19.9% to 69.9% upon completion Expected to deliver pro forma DPU accretion of 3.2%[1] Establishes a majority interest in a premium freehold asset in Sydney's core CBD Funded through debt and...
DataBeyond Showcases PICKINGMAN in Global Livestream from Operating Waste-Sorting Facility
DONGGUAN, China, Oct. 23, 2026 /PRNewswire/ -- DataBeyond showcased PICKINGMAN, its embodied AI robot for mixed municipal solid waste sorting, during the robot's first global public livestream at 8 a.m. Beijing time on October 22. The broadcast took...
Alebund Pharmaceuticals Announces Poster Presentation by Partner R1 Therapeutics of Global Phase IIb Multi-Regional Clinical Trial Design for AP306 at ASN Kidney Week 2026
SHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that its partner, R1 Therapeutics, Inc. ("R1"), presented a...
HKEX Launches AI Index, Southern Asset Management Authorised to Launch ETF
HONG KONG, Oct. 23, 2026 /PRNewswire/ -- Hong Kong Exchanges and Clearing Limited (HKEX) today announced the launch of the HKEX Artificial Intelligence Index (HKEX AI). As HKEX's first AI-themed index, HKEX AI offers investors a clearly defined,...
JinkoSolar Completes Name Change to Jinko Holdings Limited
ADSs continue to trade under "JKS"; Company to Enhance Transparency on Strategic Investment Portfolio SHANGRAO, China, Oct. 23, 2026 /PRNewswire/ -- Jinko Holdings Limited ("Jinko Holdings" or the "Company") (NYSE: JKS), formerly JinkoSolar Holding...
Studsvik and ReNu Industries partner to bring inDRUM waste treatment technology to Fukushima
Studsvik AB and ReNu Industries Inc. will adapt Studsvik's inDRUM technology for radioactive waste treatment to Japanese conditions, with the aim of building a pilot plant in Fukushima. Studsvik's Japanese subsidiary, Studsvik Japan, Ltd., and ReNu...
ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026
SEOUL, South Korea and COLOGNE, Germany, Oct. 23, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for rare and intractable diseases, today announced that its...
Harbour BioMed Receives China NMPA Approval of Batoclimab Injection (Subcutaneous Injection) for the Treatment of Generalized Myasthenia Gravis
The first NMPA-approved anti-FcRn therapy to complete its full clinical development for gMG patients in China CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global...
![[China's Voice] Preclinical Animal Study: Domestic Neurointerventional Robotic System PANVIS STAR® Completes Validation of Five Major Neurointerventional Procedures](http://prnewswire.vietreader.com/thumb/190x300/2026-10/chinas-voice-preclinical-animal-study-domestic-neurointerventional-robotic-system-panvis-star-completes-validation-of-five-major-neurointerventional-procedures-1.jpg)
[China's Voice] Preclinical Animal Study: Domestic Neurointerventional Robotic System PANVIS STAR® Completes Validation of Five Major Neurointerventional Procedures
SHANGHAI, Oct. 22, 2026 /PRNewswire/ -- Neurointerventional robots have long remained at the stage of "only being able to assist with angiography." Through close medical-engineering collaboration with Professor Jianmin Liu's team at Shanghai...